Company: TYRA
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001193125-25-085709
Chunk: 13

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 13
---
 the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following election. The following table summarizes the class, independence and committee membership of our directors:NameAgePositionIndependentCommittee MembershipCLASS I DIRECTORS—Nominated forRe-electionwith a Term to Expire at the 2028 Annual MeetingTodd Harris, Ph.D.45President, CEO and DirectorAdele M. Gulfo62DirectorXCompensationS. Michael Rothenberg, M.D., Ph.D.55DirectorXScience and TechnologyCLASS II DIRECTORS—Terms to Expire at the 2026 Annual MeetingGilla Kaplan, Ph.D.77DirectorXNominating and Corporate Governance; Science and TechnologySusan Moran, M.D., M.S.C.E.55DirectorXCompensation (Chair); Science and TechnologyRobert More57Chairman of the BoardXAudit; Nominating and Corporate Governance (Chair)CLASS III DIRECTORS—Terms to Expire at the 2027 Annual MeetingMelissa McCracken, Ph.D.38DirectorXAudit; Science and TechnologyJake Simson, Ph.D.39DirectorXNominating and Corporate Governance; Science and Technology (Chair)Rehan Verjee44DirectorXAudit (Chair); CompensationThe division of our Board into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control of our Company. Our directors may be removed only for cause and only by the affirmative vote of the holders of at leasttwo-thirdsof the voting power of the then-outstanding shares of capital stock entitled to vote in the election of directors.In the event any of the nominees should become unable to serve, or for good cause will not serve, as a director, it is intended that votes will be cast for a substitute nominee designated by the Board or the Board may elect to reduce its size. The Board has no reason to believe that the nominees named below will be unable to serve if elected. Each of the nominees has consented to being named in this proxy statement and to serve if elected.All of the persons whose names and biographies appear below are currently serving as our directors. Each of our directors brings to the Board significant leadership experience derived from their professional experience and service as executives or board members of other corporations and/or private equity and venture capital firms. The process undertaken by the Nominating and Corporate Governance Committee in recommending qualified director candidates is described below under “Board Qualifications and Director Nomination Process.”